Dow Jones

44 296,51

0,97%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Elite Pharmaceuticals Inc (QB) (ELTP)
Elite Pharmaceuticals Inc (QB) (ELTP) Actualités

ELTP

Elite Pharmaceuticals (QB) (ELTP)

Elite Pharmaceuticals Inc (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ELTP

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
18/11/2024	22h35	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
14/11/2024	22h30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
28/10/2024	22h23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
23/10/2024	14h27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
23/10/2024	14h03	InvestorsHub NewsWire	ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
16/11/2023	13h32	InvestorsHub NewsWire	Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
31/07/2023	22h20	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
29/06/2023	23h15	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
29/06/2023	22h44	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
29/06/2023	22h43	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
26/06/2023	18h47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
14/02/2023	22h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
03/06/2022	16h06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
07/03/2022	14h10	InvestorsHub NewsWire	Trump's SPAC, Electric Vehicles, a Drug Manufacturer and a Corporate Shake-Up at the Top Make These Stocks Worth Investigating, Major Copper Find Feature Report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
01/09/2020	22h04	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
31/07/2020	23h01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
28/07/2020	12h05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
27/07/2020	23h25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
15/07/2020	23h03	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
13/07/2020	18h50	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
06/07/2020	15h16	InvestorsHub NewsWire	The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
11/05/2020	22h51	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
29/04/2020	23h22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
17/04/2020	22h42	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
14/06/2019	19h00	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
17/10/2018	23h17	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
06/09/2018	17h38	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
02/06/2017	19h46	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
17/11/2016	22h05	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
27/07/2016	15h00	InvestorsHub NewsWire	Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)